Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: The influence of pituitary magnetic resonance imaging findings

被引:57
作者
Coutant, R
Rouleau, S
Despert, F
Magontier, N
Loisel, D
Limal, JMA
机构
[1] Univ Hosp, Dept Pediat, F-49000 Angers, France
[2] Univ Hosp, Dept Radiol, F-49000 Angers, France
[3] Univ Hosp, Dept Pediat, F-37000 Tours, France
关键词
D O I
10.1210/jc.86.10.4649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed the final height of 146 short children with either nonacquired GH deficiency or idiopathic short stature. Our purpose was 1) to assess growth according to the pituitary magnetic resonance imaging findings in the 63 GH-treated children with GH deficiency and 2) to compare the growth of the GH-deficient patients with normal magnetic resonance imaging (n = 48) to that of 32 treated and 51 untreated children with idiopathic short stature (GH peak to provocative tests >10 mug/liter). The mean GH dose was 0.44 IU/kg.wk (0.15 mg/kg-wk), given for a mean duration of 4.6 yr. Among the GH-deficient children, 15 had hypothalamic-pituitary abnormalities (stalk agenesis), all with total GH deficiency (GH peak <5 <mu>g/liter). They were significantly shorter and younger at the time of diagnosis than those with normal magnetic resonance imaging, had better catch-up growth (+2.7 +/- 0.9 vs. +1.3 +/- 0.8 SD score; P < 0.01), and reached greater final height (-1.1 +/- 1.0 vs. -1.7 +/- 1.0 SD score; P < 0.05). Among patients with normal magnetic resonance imaging, there was no difference in catch-up growth and final height between partial and total GH deficiencies. GH-deficient subjects with normal magnetic resonance imaging and treated and untreated patients with idiopathic short stature had comparable auxological characteristics, age at evaluation, and target height. Although they had different catch-up growth (+1.3 +/- 0.8, +0.9 +/- 0.6, and +0.7 +/- 0.9 SD score, respectively; P < 0.01, by ANOVA), these patients reached a similar final height (-1.7 +/- 1.0, -2.1 +/- 0.8, and -2.1 +/- 1.0 SD score, respectively; P = 0.13). Pituitary magnetic resonance imaging findings show the heterogeneity within the group of nonacquired GH deficiency and help to predict the response to GH treatment in these patients. The similarities in growth between the GH-deficient children with normal magnetic resonance imaging and those with idiopathic short stature suggest that the short stature in the former subjects is at least partly due to factors other than GH deficiency.
引用
收藏
页码:4649 / 4654
页数:6
相关论文
共 41 条
[21]   THE EFFICACY OF GROWTH-HORMONE IN DIFFERENT TYPES OF GROWTH FAILURE - AN ANALYSIS OF 101 CASES [J].
LENKO, HL ;
LEISTI, S ;
PERHEENTUPA, J .
EUROPEAN JOURNAL OF PEDIATRICS, 1982, 138 (03) :241-249
[22]   Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood [J].
Longobardi, S ;
Merola, B ;
Pivonello, R ;
DiRella, F ;
DiSomma, C ;
Colao, A ;
Ghigo, E ;
Camanni, F ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1244-1247
[23]   Growth hormone (GH) deficiency (GHD) of childhood onset: Reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults [J].
Maghnie, M ;
Strigazzi, C ;
Tinelli, C ;
Autelli, M ;
Cisternino, M ;
Loche, S ;
Severi, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1324-1328
[24]   THE EFFECTS OF ESTROGEN PRIMING AND PUBERTY ON THE GROWTH-HORMONE RESPONSE TO STANDARDIZED TREADMILL EXERCISE AND ARGININE-INSULIN IN NORMAL GIRLS AND BOYS [J].
MARIN, G ;
DOMENE, HM ;
BARNES, KM ;
BLACKWELL, BJ ;
CASSORLA, FG ;
CUTLER, GB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) :537-541
[25]   VARIATIONS IN PATTERN OF PUBERTAL CHANGES IN GIRLS [J].
MARSHALL, WA ;
TANNER, JM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1969, 44 (235) :291-+
[26]   VARIATIONS IN PATTERN OF PUBERTAL CHANGES IN BOYS [J].
MARSHALL, WA ;
TANNER, JM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1970, 45 (239) :13-+
[27]  
NAGEL BHP, 1999, GROWTH HORMONE THERA, P65
[28]   Pituitary stalk interruption syndrome: A clinical-biological-genetic assessment of its pathogenesis [J].
Pinto, G ;
Netchine, I ;
Sobrier, ML ;
Brunelle, F ;
Souberbielle, JC ;
Brauner, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3450-3454
[29]  
Ranke M B, 1991, Acta Paediatr Scand Suppl, V379, P87
[30]   Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency - Analysis of 195 patients of the Kabi Pharmacia International Growth Study [J].
Ranke, MB ;
Price, DA ;
AlbertssonWikland, K ;
Maes, M ;
Lindberg, A .
HORMONE RESEARCH, 1997, 48 (02) :62-71